Suppr超能文献

两名日本患者患有类努南综合征样疾病伴生长期毛发疏松 2。

Two Japanese patients with Noonan syndrome-like disorder with loose anagen hair 2.

机构信息

Department of Pediatrics, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.

Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.

出版信息

Am J Med Genet A. 2022 Jul;188(7):2246-2250. doi: 10.1002/ajmg.a.62733. Epub 2022 Mar 25.

Abstract

Noonan syndrome-like disorder with loose anagen hair (NSLH) is a rare disease characterized by typical features of Noonan syndrome with additional findings of relative or absolute macrocephaly, loose anagen hair, and a higher incidence of intellectual disability. NSLH1 is caused by a heterozygous mutation in the SHOC2 gene on chromosome 10q25, and NLSH2 is caused by a heterozygous mutation in the Protein phosphatase one catalytic subunit beta (PPP1CB) gene on chromosome 2p23. Protein phosphatase1 (PP1), encoded by PPP1CB, forms a complex with SHOC2 and dephosphorylates RAFs, which results in activation of the signaling cascade and contribution to Noonan syndrome pathogenesis. Here, we report two genetically confirmed Japanese patients with NSLH2 having the same de novo mutation in PPP1CB presenting prominent-hyperteloric-appearing eyes and a tall forehead similar to individuals carrying a mutation in PPP1CB, c.146C > G; p.Pro49Arg, which is different from typical facial features of Noonan syndrome. They also showed short stature, absolute macrocephaly, and loose anagen hair like NSLH1: however, growth hormone deficiency often seen in NSLH1 caused by SHOC2 mutation was absent. Although a number of Noonan syndrome and NSLH1 patients have shown blunted or no response to GH therapy, linear growth was promoted by recombinant human growth hormone (rhGH) in one of our patients. Since another NSLH2 patient with good response to rhGH treatment was reported, rhGH therapy may be effective in patients with NSLH2.

摘要

类努南综合征伴生长期毛发疏松(NSLH)是一种罕见疾病,其特征为具有典型努南综合征特征,并有相对或绝对大头畸形、生长期毛发疏松,以及智力残疾发病率较高等额外表现。NSLH1 由染色体 10q25 上的 SHOC2 基因杂合突变引起,NSLH2 由染色体 2p23 上的蛋白磷酸酶 1 催化亚基β(PPP1CB)基因杂合突变引起。由 PPP1CB 编码的蛋白磷酸酶 1(PP1)与 SHOC2 形成复合物,使 RAF 去磷酸化,从而激活信号级联反应,并促成努南综合征的发病机制。在此,我们报告了两名经基因证实的日本 NSLH2 患者,他们均携带 PPP1CB 上的新生杂合突变,表现出突出的、高拱的眼睛和高高的额头,类似于携带 PPP1CB 突变的个体,c.146C > G;p.Pro49Arg,这与典型的努南综合征面部特征不同。他们还表现出身材矮小、绝对大头畸形和生长期毛发疏松,类似于 NSLH1:然而,常出现在由 SHOC2 突变引起的 NSLH1 中的生长激素缺乏症并不存在。尽管许多努南综合征和 NSLH1 患者对 GH 治疗表现出迟钝或无反应,但在我们的一名患者中,重组人生长激素(rhGH)促进了线性生长。由于报道了另一名对 rhGH 治疗反应良好的 NSLH2 患者,rhGH 治疗可能对 NSLH2 患者有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验